4//SEC Filing
Schwartz Matthew Wilson 4
Accession 0001493152-24-004015
CIK 0001362703other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:17 PM ET
Size
14.2 KB
Accession
0001493152-24-004015
Insider Transaction Report
Form 4
Schwartz Matthew Wilson
Director
Transactions
- Other
Common Stock Purchase Warrant
2022-11-29+4,201,681→ 4,201,681 totalExercise: $0.00From: 2022-07-01Exp: 2027-04-01→ Common Stock (4,201,681 underlying) - Other
10% O.I.D. Senior Secured Convertible Debenture
2022-11-29Exercise: $0.00From: 2023-11-29Exp: 2023-11-29→ Common Stock (40,332,963 underlying) - Other
Common Stock Purchase Warrant
2022-11-29+34,571,111→ 34,571,111 totalExercise: $0.00From: 2023-11-29Exp: 2029-05-29→ Common Stock (34,571,111 underlying) - Other
8% Convertible Promissory Note
2022-11-29Exercise: $0.00From: 2022-07-01Exp: 2027-04-01→ Common Stock (21,008,403 underlying)
Footnotes (6)
- [F1]Assumes a fixed conversion price of $0.003, but such conversion price is subject to adjustment as set forth in the debenture and warrant, respectively.
- [F2]The Reporting Person was issued a 10% Original Issue Discount ("O.I.D.") Senior Secured Convertible Debenture in the principal amount of $120,998.89 and 34,571,111 warrants in exchange for the 8% Convertible Promissory Note in the principal amount of $105,216 previously issued to the Reporting Person.
- [F3]The debenture and warrants described in footnote 2 are subject to mandatory conversion upon the occurrence of certain events, as outlined in the debentures and warrants, respectively. The original maturity date of the debentures was subsequently extended to February 29, 2024.
- [F4]Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock.
- [F5]Expiration Date in the event a Qualified Offering is not consummated prior to the maturity date of the debentures the Warrants are issued in connection with.
- [F6]In connection with the note exchange describe in footnote 2, the Reporting Person entered into an amendment to its previously issued Common Stock Purchase Warrant amending the exercise price to $0.003 (and subject to adjustment in the event of certain fundamental transactions described in the amended warrant).
Documents
Issuer
THERALINK TECHNOLOGIES, INC.
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001923495
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 6:17 PM ET
- Size
- 14.2 KB